Skip to main content
Premium Trial:

Request an Annual Quote

Robin Stracey New CEO of Applied Imaging, Janet Lankard Goes from Affy to Quantum Dot, Chandu Ammini Joins Benitec as Business Development Manager, and Others

Applied Imaging will promote Robin Stracey, president and COO, to the position of president and CEO on Jan.1, the company said last week. He will replace Carl Hull, who will resign on Dec. 31, as previously announced. Hullwill remain a company director. Stracey joined Applied Imaging in Nov. 2003. Prior to this, he was vice president and general manager of the chromatography and mass spectrometry business unit at Thermo Electron. Stracey holds a BS in life sciences from the Universityof Nottingham in the UKand is a graduate of the executive program at the Stanford University Graduate School of Business.


Janet Lankard has become vice president of sales for Quantum Dot, the company said last week. He will lead the sales team for Quantum Dot's upcoming launch of the Mosaic Gene Expression Assay system. Lankard formerly was a director of sales for Affymetrix, which she joined in 1998. She has also been an executive sales account manager with Applied Biosystems. Lankard holds a BA in biochemistry from Cal Poly San Luis Obispo.


Chandu Ammini joined Benitec in October as manager of business development. Before joining the company, he was a biotech consultant at Bethesda Bioscience Partners. Prior to that, he worked as a business development associate for MacroGenics. Ammini holds a PhD in molecular genetics and microbiology from the Universityof Florida and an MBA in finance from the Robert H. Smith School of Business at the Universityof Maryland.


Nicolas Roelofs, chief operating officer of Stratagene, will resign by the end of the year to take a position closer to his family, the company said in an SEC filing last week. Stratagene's CEO Joseph Sorge will assume Roelofs' responsibilities until the company finds a successor.


Daniel Shaughnessy, senior vice president of corporate development, general counsel, and corporate secretary of Charles River Laboratories, will leave his posts at the end of the year, the company said last week. He will join the faculty of NortheasternUniversity's Collegeof Business Administration. Jody Acford will replace Shaughnessy in his roles. She joins Charles River Laboratories from John Hancock Financial Services, where she was senior vice president and deputy general counsel.


Todd Smithhas been appointed as science and technology advisor of Moliris, the Fort Worth, Texas-based antibiotic drug discovery company said yesterday. He is the CEO and chairman of Geospiza, and a specialist in bioinformatics and medicinal chemistry, emphasizing the cloning and sequencing of antibiotic biosynthesis genes, according to Moliris.


Heather Kowalski, Craig Venter's long-term spokeswoman and vice president of policy and planning at the J. Craig Venter Institute, has left her post to take a position at an undisclosed public relations firm in Boston, GenomeWeb News has learned. She was replaced by Melanie Wranaker.


Lander Brown has become vice president of human resources and administration of Third Wave Technologies, the company said on Monday. Previously, he was executive vice president of human resources and a member of the USoperating board of Leo Burnett USA. Brown holds a master's degree in human resource management from National-Louis University in Evanston, Ill., and a bachelor's degree in social science from Michigan State University.


Philip Petraglia has become controller of the Pittsburgh Life Sciences Greenhouse, PLSG said today. He joins the public/private biotech investment partnership from Resources Connection, a professional services firm. Petraglia holds a bachelor's degree from WestminsterCollegein New Wilmington, Pa.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.